C19orf10 is expressed in various tissues, including the bone marrow, spleen stroma cells, resting mononuclear cells, and activated CD8+ T cells . It plays a crucial role in the immune system, particularly in the regulation of T-cell responses. The protein is involved in the growth and differentiation of stromal cells, which are essential for the formation and maintenance of the bone marrow microenvironment .
The recombinant form of C19orf10 is produced using genetic engineering techniques. This involves inserting the gene encoding C19orf10 into a suitable expression system, such as bacteria or mammalian cells, to produce the protein in large quantities. The recombinant protein is then purified and used for various research and therapeutic purposes .
Research on C19orf10 has provided insights into its role in immune regulation and its potential therapeutic applications. Studies have shown that C19orf10 can modulate the activity of immune cells, making it a potential target for immunotherapy. Additionally, the protein’s involvement in stromal cell growth and differentiation suggests its potential use in regenerative medicine and tissue engineering .